Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Rubicon Research Business Update

Rubicon Research Limited announced the successful conclusion of an unannounced USFDA inspection at its R&D facility in Concord, Ontario, Canada. The inspection, conducted from April 20 to April 24, 2026, concluded without any Form-483 observations being issued. This outcome confirms the company's adherence to high quality and compliance standards.

Source

NSE filing, NSE: RUBICON. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Rubicon Research Ltd: key numbers

Share price
₹1,564.00
Market cap
₹25,889 Cr
Revenue (annual)
₹1,754 Cr
Net profit (annual)
₹246.7 Cr
P/E (TTM)
89.8×Sector 46.1×
Promoter holding
51.25%-8.51% QoQ
FII holding
9.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Rubicon Research Ltd

All →

Other business update announcements

All →